Discontinued — last reported Q2 '24
Non-Current Assets
AFS Securities
Gilead Sciences AFS Securities increased by 4.6% to $1.99B in Q3 2025 compared to the prior quarter. Over 3 years (FY 2020 to FY 2023), AFS Securities shows an upward trend with a 6.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ2 2024
Parent metricTotal investment securities
How to read this metric
An increase reflects capital allocation toward investment portfolios, while a decrease may signal portfolio rebalancing or asset liquidation.
Detailed definition
Available-for-sale securities are debt or equity investments that are not classified as trading or held-to-maturity, and...
Peer comparison
Common in the investment portfolios of banks and insurance companies.
Metric ID:
fin_afs_securitiesHistorical Data
13 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $814.00M | $1.08B | $2.50B | $1.40B | $1.31B | $1.27B | $2.29B | $1.31B | $1.31B | $1.15B | $2.43B | $1.91B | $1.99B |
| QoQ Change | — | +32.1% | +132.3% | -44.1% | -6.0% | -3.4% | +80.8% | -43.0% | +0.4% | -12.6% | +111.5% | -21.4% | +4.6% |
| YoY Change | — | — | — | — | +61.3% | +18.0% | -8.2% | -6.4% | +0.0% | -9.5% | +5.8% | — | — |
Range$814.00M – $2.50B
CAGR+34.8%
Avg YoY Growth+8.7%
Median YoY Growth+0.0%
AFS Securities at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's afs securities?
- Gilead Sciences (GILD) reported afs securities of $1.99B in Q3 2025.
- What is the long-term trend for Gilead Sciences's afs securities?
- Over 3 years (2020 to 2023), Gilead Sciences's afs securities has grown at a 6.2% compound annual growth rate (CAGR), from $2.03B to $2.43B.
- What does afs securities mean?
- Investments in securities that are held for potential sale and marked to fair market value.